The presence of CKD among patients with SJS or TEN may influence the in-hospital mortality risk associated with analgesic and antipyretic therapies.
First identified by Stevens and Johnson in 1922, SJS and TEN are now recognized as disorders with a continuum of severity, from milder forms (SJS) to the most severe (TEN). SJS/TEN is associated with ...
Please provide your email address to receive an email when new articles are posted on . The eyes of patients with SJS/TEN should be urgently evaluated and treated to avoid sequelae. Cryopreserved ...
New data builds on award-winning research and confirms efficacy and safety of PC111 across in-vitro, ex-vivo, and in-vivo humanized models JERUSALEM, July 29, 2025 /PRNewswire/ -- Scinai ...
First identified by Stevens and Johnson in 1922, SJS and TEN are now recognized as disorders with a continuum of severity, from milder forms (SJS) to the most severe (TEN). SJS/TEN is associated with ...
"A new nationwide study in Taiwan reveals that survivors of severe drug reactions—known as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)—face a heightened risk of heart disease ...
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic ...
Postmarket surveillance data revealed that enfortumab vedotin (EV) skin toxicity is associated with high hospitalization and mortality rates, especially with Stevens-Johnson syndrome/toxic epidermal ...
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) survivors encounter rare, life-threatening drug reactions and years of physical, emotional and social consequences long after ...
Purpose: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) associated with the use of nonsteroidal antiinflammatory drugs (NSAIDs) are described. Summary: A search of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results